Investors

Investors

Model
Medicines
is
advancing
a
new generation
new generation
of
therapeutics
that
redefine
what
is
possible
in
modern
drug discovery

Led by experts in AI/ML, chemistry, and drug development, our team harnesses cutting-edge informatics to build a robust pipeline of novel medicines targeting underserved diseases, transforming traditional drug discovery through technological innovation.

Our Founders

A Founding Team with Experience in FDA-Approvals

20

Investigational New Drug Applications

12

New Drug Applications

2

Canada + EU Applications

20

Abbreviated New Drug Applications

20

Investigational New Drug Applications

2

Canada + EU Applications

12

New Drug Applications

20

Abbreviated New Drug Applications

Built from real drug development experience

Founding team experience spans approved and submitted therapies across ophthalmology, neurology, virology, immunology, and endocrinology.

Experience across recognized biopharma companies

Multiple therapeutic categories

Regulatory depth across pathways

Visualization of Model Medicines founding team experience across INDs, NDAs, ANDAs, and international regulatory applications
Representative approved therapies associated with Model Medicines founding team drug development experience
Biopharma company experience associated with the Model Medicines founding team, including LuxBio, Sage Therapeutics, Sun Pharma, and Bristol Myers Squibb
Scientific visualization representing Model Medicines founding team experience across ophthalmology, neurology, virology, immunology, and endocrinology

Built from real drug development experience

Founding team experience spans approved and submitted therapies across ophthalmology, neurology, virology, immunology, and endocrinology.

Experience across recognized biopharma companies

Multiple therapeutic categories

Regulatory depth across pathways

Visualization of Model Medicines founding team experience across INDs, NDAs, ANDAs, and international regulatory applications
Representative approved therapies associated with Model Medicines founding team drug development experience
Biopharma company experience associated with the Model Medicines founding team, including LuxBio, Sage Therapeutics, Sun Pharma, and Bristol Myers Squibb
Scientific visualization representing Model Medicines founding team experience across ophthalmology, neurology, virology, immunology, and endocrinology

Built from real drug development experience

Founding team experience spans approved and submitted therapies across ophthalmology, neurology, virology, immunology, and endocrinology.

Experience across recognized biopharma companies

Multiple therapeutic categories

Regulatory depth across pathways

Visualization of Model Medicines founding team experience across INDs, NDAs, ANDAs, and international regulatory applications
Representative approved therapies associated with Model Medicines founding team drug development experience
Biopharma company experience associated with the Model Medicines founding team, including LuxBio, Sage Therapeutics, Sun Pharma, and Bristol Myers Squibb
Scientific visualization representing Model Medicines founding team experience across ophthalmology, neurology, virology, immunology, and endocrinology

Team

Illustrated portrait of Daniel Haders II, Ph.D, Founder, CEO of Model Medicines

Daniel Haders II, Ph.D

Founder, CEO

Illustrated portrait of Sean Russell, Founder, Chief Operating Officer of Model Medicines

Sean Russell

Founder, Chief Operating Officer

Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships and Investor Relations

Illustrated portrait of Tyler Umansky, Head of Platform and Machine Learning of Model Medicines

Tyler Umansky

Head of Platform and Machine Learning

Illustrated portrait of Virgil Woods, Ph.D, Senior Scientist of Model Medicines

Virgil Woods, Ph.D

Senior Scientist

Illustrated portrait of Jacqueline Malvin, Machine Learning Fellow of Model Medicines

Jacqueline Malvin

Machine Learning Fellow

Illustrated portrait of Suryansh Ankur, Machine Learning Fellow of Model Medicines

Suryansh Ankur

Machine Learning Fellow

Senior Advisors

Illustrated portrait of Davey Smith, MD, MAS, FACP, FIDSA, Lead Clinical Advisor of Model Medicines

Davey Smith, MD, MAS, FACP, FIDSA

Lead Clinical Advisor

Illustrated portrait of Launa Aspeslet, Ph.D, Senior Scientific & Clinical Advisor of Model Medicines

Launa Aspeslet, Ph.D

Senior Scientific & Clinical Advisor

Illustrated portrait of Philippe A. Gallay, Ph.D, Preclinical Advisor of Model Medicines

Philippe A. Gallay, Ph.D

Preclinical Advisor

Invested in Our Success

We’re backed by leading, multi-stage
investors with significant expertise and
sophistication in the Bio-IT/pharma space

We’re backed by leading, multi-stage
investors with significant expertise and
sophistication in the
Bio-IT/pharma space.

Scientific and Industry Advisors

Illustrated portrait of Adolfo Garcia-Sastre, Ph.D, Preclinical Development Partner & Advisor of Model Medicines

Adolfo Garcia-Sastre, Ph.D

Preclinical Development Partner & Advisor

Illustrated portrait of Adolfo Garcia-Sastre, Ph.D, Preclinical Development Partner & Advisor of Model Medicines

Adolfo Garcia-Sastre, Ph.D

Preclinical Development Partner & Advisor

Illustrated portrait of Kris White, Ph.D, Preclinical Development Partner & Advisor of Model Medicines

Kris White, Ph.D

Preclinical Development Partner & Advisor

Illustrated portrait of Kris White, Ph.D, Preclinical Development Partner & Advisor of Model Medicines

Kris White, Ph.D

Preclinical Development Partner & Advisor

Illustrated portrait of Tushar Menon, Ph.D, Scientific Advisor of Model Medicines

Tushar Menon, Ph.D

Scientific Advisor

Illustrated portrait of Tushar Menon, Ph.D, Scientific Advisor of Model Medicines

Tushar Menon, Ph.D

Scientific Advisor

Illustrated portrait of David Garvey, Ph.D, Preclinical Advisor of Model Medicines

David Garvey, Ph.D

Preclinical Advisor

Illustrated portrait of David Garvey, Ph.D, Preclinical Advisor of Model Medicines

David Garvey, Ph.D

Preclinical Advisor

Illustrated portrait of William Brubaker, Ph.D, Preclinical Development Advisor of Model Medicines

William Brubaker, Ph.D

Preclinical Development Advisor

Illustrated portrait of William Brubaker, Ph.D, Preclinical Development Advisor of Model Medicines

William Brubaker, Ph.D

Preclinical Development Advisor

Illustrated portrait of James Weber, Health Economist of Model Medicines

James Weber

Health Economist

Illustrated portrait of James Weber, Health Economist of Model Medicines

James Weber

Health Economist